Spectropathology for the next generation: quo vadis?

Hugh J Byrne, Malgorzata Baranska, Gerwin J Puppels, Nick Stone, Bayden Robert Wood, Kathleen M Gough, Peter Lasch, Philip Robert Heraud, Josep Sule-Suso, Ganesh D Sockalingum

Research output: Contribution to journalEditorialResearchpeer-review

56 Citations (Scopus)

Abstract

Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.
Original languageEnglish
Pages (from-to)2066 - 2073
Number of pages8
JournalThe Analyst
Volume140
Issue number7
DOIs
Publication statusPublished - 2015

Cite this

Byrne, H. J., Baranska, M., Puppels, G. J., Stone, N., Wood, B. R., Gough, K. M., ... Sockalingum, G. D. (2015). Spectropathology for the next generation: quo vadis? The Analyst, 140(7), 2066 - 2073. https://doi.org/10.1039/c4an02036g
Byrne, Hugh J ; Baranska, Malgorzata ; Puppels, Gerwin J ; Stone, Nick ; Wood, Bayden Robert ; Gough, Kathleen M ; Lasch, Peter ; Heraud, Philip Robert ; Sule-Suso, Josep ; Sockalingum, Ganesh D. / Spectropathology for the next generation: quo vadis?. In: The Analyst. 2015 ; Vol. 140, No. 7. pp. 2066 - 2073.
@article{889c3bc6028a4c149715169d71bfa221,
title = "Spectropathology for the next generation: quo vadis?",
abstract = "Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.",
author = "Byrne, {Hugh J} and Malgorzata Baranska and Puppels, {Gerwin J} and Nick Stone and Wood, {Bayden Robert} and Gough, {Kathleen M} and Peter Lasch and Heraud, {Philip Robert} and Josep Sule-Suso and Sockalingum, {Ganesh D}",
year = "2015",
doi = "10.1039/c4an02036g",
language = "English",
volume = "140",
pages = "2066 -- 2073",
journal = "The Analyst",
issn = "0003-2654",
publisher = "The Royal Society of Chemistry",
number = "7",

}

Byrne, HJ, Baranska, M, Puppels, GJ, Stone, N, Wood, BR, Gough, KM, Lasch, P, Heraud, PR, Sule-Suso, J & Sockalingum, GD 2015, 'Spectropathology for the next generation: quo vadis?', The Analyst, vol. 140, no. 7, pp. 2066 - 2073. https://doi.org/10.1039/c4an02036g

Spectropathology for the next generation: quo vadis? / Byrne, Hugh J; Baranska, Malgorzata; Puppels, Gerwin J; Stone, Nick; Wood, Bayden Robert; Gough, Kathleen M; Lasch, Peter; Heraud, Philip Robert; Sule-Suso, Josep; Sockalingum, Ganesh D.

In: The Analyst, Vol. 140, No. 7, 2015, p. 2066 - 2073.

Research output: Contribution to journalEditorialResearchpeer-review

TY - JOUR

T1 - Spectropathology for the next generation: quo vadis?

AU - Byrne, Hugh J

AU - Baranska, Malgorzata

AU - Puppels, Gerwin J

AU - Stone, Nick

AU - Wood, Bayden Robert

AU - Gough, Kathleen M

AU - Lasch, Peter

AU - Heraud, Philip Robert

AU - Sule-Suso, Josep

AU - Sockalingum, Ganesh D

PY - 2015

Y1 - 2015

N2 - Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.

AB - Although the potential of vibrational spectroscopy for biomedical applications has been well demonstrated, translation into clinical practice has been relatively slow. This Editorial assesses the challenges facing the field and the potential way forward. While many technological challenges have been addressed to date, considerable effort is still required to gain acceptance of the techniques among the medical community, standardise protocols, extend to a clinically relevant scale, and ultimately assess the health economics underlying clinical deployment. National and international research networks can contribute much to technology development and standardisation. Ultimately, large-scale funding is required to engage in clinical trials and instrument development.

UR - http://pubs.rsc.org.ezproxy.lib.monash.edu.au/en/content/articlepdf/2015/an/c4an02036g

U2 - 10.1039/c4an02036g

DO - 10.1039/c4an02036g

M3 - Editorial

VL - 140

SP - 2066

EP - 2073

JO - The Analyst

JF - The Analyst

SN - 0003-2654

IS - 7

ER -

Byrne HJ, Baranska M, Puppels GJ, Stone N, Wood BR, Gough KM et al. Spectropathology for the next generation: quo vadis? The Analyst. 2015;140(7):2066 - 2073. https://doi.org/10.1039/c4an02036g